March begins human trials for vaccine to slow Aids
Merck is beginning critical human trials for a vaccine that could prevent or decelerate HIV/ Aids infections. Merck said it has begun enrolling an expected 1500 volunteers globally to test the
Merck is beginning critical human trials for a vaccine that could prevent or decelerate HIV/ Aids infections. Merck said it has begun enrolling an expected 1500 volunteers globally to test the